S129: ADOPTIVELY INFUSED MEMORY-LIKE (ML) NATURAL KILLER (NK) CELLS ELICIT ADAPTIVE IMMUNE RESPONSES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML)

S129: ADOPTIVELY INFUSED MEMORY-LIKE (ML) NATURAL KILLER (NK) CELLS ELICIT ADAPTIVE IMMUNE RESPONSES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML)

Bibliographic Details
Main Authors:	Sergio Rutella, Amanda Cashen, John Muth, Jayakumar Vadakekolathu, Laura Arthur, Nitin Mahajan, Melissa Berrien-Elliott, Jan Davidson-Moncada, Todd Fehniger
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000967428.42997.44

Similar Items

P1426: WU-NK-101, AN ALLOGENEIC MEMORY NK CELL, FOR THE TREATMENT OF RELAPSE OR REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML)
by: J. J. Muth, et al.
Published: (2022-06-01)

332 WU-NK-101, an off-the-shelf memory NK cell product, reverses immune checkpoint inhibitor (ICB) resistance with synergistic anti-tumor activity
by: Sergio Rutella, et al.
Published: (2023-11-01)

PB2498: A PHASE 1 STUDY OF WU-NK-101 IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML)
by: Amanda Cashen, et al.
Published: (2023-08-01)

Biomarkers as targets for CAR-T/NK cell therapy in AML
by: Ruonan Shao, et al.
Published: (2023-06-01)

CD56 regulates human NK cell cytotoxicity through Pyk2
by: Justin T Gunesch, et al.
Published: (2020-06-01)

Atividade Antileucêmica das Células Natural Killer (NK)
by: Aline Almeida Oliveira, et al.
Published: (2008-09-01)

Natural Born Killers: NK Cells in Cancer Therapy
by: S. Elizabeth Franks, et al.
Published: (2020-07-01)

422 Hijacking upregulated E-selectin while boosting SDF-1α sensing rewires infused NK cells to the AML-perturbed bone marrow
by: Agneta Andersson, et al.
Published: (2023-11-01)

Nanoparticle Enhancement of Natural Killer (NK) Cell-Based Immunotherapy
by: Dhanashree Murugan, et al.
Published: (2022-11-01)

Linfoma nasal de células T/natural killer (LNT/NK)
by: Oscar Eduardo Mora Hernández, et al.
Published: (2023-11-01)

Natural Killer (NK) cells in immunotherapy and perspectives in antitumour approaches
by: Lu Yihua
Published: (2022-01-01)

Cytokine‐Induced Memory‐Like NK Cells: Emerging strategy for AML immunotherapy
by: Mehdi Bakhtiyaridovvombaygi, et al.
Published: (2023-12-01)

Sialylation of Human Natural Killer (NK) Cells Is Regulated by IL-2
by: Philip Rosenstock, et al.
Published: (2020-06-01)

Enhancing a Natural Killer: Modification of NK Cells for Cancer Immunotherapy
by: Rasa Islam, et al.
Published: (2021-04-01)

Non-Genetically Improving the Natural Cytotoxicity of Natural Killer (NK) Cells
by: Martin Villalba, et al.
Published: (2020-01-01)

Donor selection for adoptive immunotherapy with NK cells in AML patients: Comparison between analysis of lytic NK cell clones and phenotypical identification of alloreactive NK cell repertoire
by: Raffaella Meazza, et al.
Published: (2023-02-01)

Tissue-resident natural killer (NK) cells are cell lineages distinct from thymic and conventional splenic NK cells
by: Dorothy K Sojka, et al.
Published: (2014-04-01)

EVALUATION OF TOXICITY OF INFUSION SOLUTION OF POTASSIUM AND MAGNESIUM ASPARAGINATE 500 ML IN EXPERIMENT
by: A. G. Yushkov, et al.
Published: (2012-07-01)

Phenotypic and functional characterisation of natural killer (NK) receptor expressing T lymphocytes in spondyloarthritis
by: Chan, A, et al.
Published: (2005)

EVALUATION OF MICROVESICLES FORMED BY NATURAL KILLER (NK) CELLS USING FLOW CYTOMETRY
by: V. A. Mikhailova, et al.
Published: (2018-03-01)

Deciphering the Immunological Phenomenon of Adaptive Natural Killer (NK) Cells and Cytomegalovirus (CMV)
by: Samantha Barnes, et al.
Published: (2020-11-01)

Strategies to Augment Natural Killer (NK) Cell Activity against Solid Tumors
by: Ziqing Chen, et al.
Published: (2019-07-01)

RNAi-Mediated Screen of Primary AML Cells Nominates MDM4 as a Therapeutic Target in NK-AML with <i>DNMT3A</i> Mutations
by: Olga Alexandra Sidorova, et al.
Published: (2022-03-01)

Human natural killer (NK) cell activation by luteolin from Brucea javanica leaves
by: Ismail, Norzila, et al.
Published: (2018)

The nature of the natural killer (NK) cell of human intestinal mucosa and mesenteric lymph node.
by: Gibson, P, et al.
Published: (1985)

Selective modulation of Natural Killer (NK) cell phenotypes through chromatin modifying mechanisms
by: Cribbs, A, et al.
Published: (2016)

Natural Killer Cell Line NK-92-Mediated Damage of Medically Important Fungi
by: Stanislaw Schmidt, et al.
Published: (2021-02-01)

PB1715: UNLEASHING NATURAL KILLER (NK) CELLS TO PROMOTE ANTI-LEUKEMIC IMMUNITY
by: Ioanna Tsoukala, et al.
Published: (2023-08-01)

The Role of Natural Killer (NK) Cells in Acute Coronary Syndrome: A Comprehensive Review
by: Marko Kumrić, et al.
Published: (2020-11-01)

Cordycepin Sensitizes Cholangiocarcinoma Cells to Be Killed by Natural Killer-92 (NK-92) Cells
by: Suthida Panwong, et al.
Published: (2021-10-01)

Harnessing allogeneic NK cells: improving outcomes with tailored donor lymphocyte infusion
by: Shannon R. McCurdy
Published: (2022-06-01)

Symptomatic Carotid Atherosclerotic Plaques Are Associated With Increased Infiltration of Natural Killer (NK) Cells and Higher Serum Levels of NK Activating Receptor Ligands
by: Irene Bonaccorsi, et al.
Published: (2019-07-01)

TO THE POSSIBILITY OF REVEALING OF SIDE EFFECTS OF METRONIDAZOLE (0,5% INFUSION SOLUTION, 100 ML) IN EXPERIMENT
by: A. G. Yushkov, et al.
Published: (2012-07-01)

CD56dimCD16dim Natural Killer (NK) Cells: The Forgotten Population
by: Jacques Zimmer
Published: (2020-04-01)

Successful expansion and cryopreservation of human natural killer cell line NK-92 for clinical manufacturing.
by: Seul Lee, et al.
Published: (2024-01-01)

Preclinical Evaluation of CRISPR-Edited CAR-NK-92 Cells for Off-the-Shelf Treatment of AML and B-ALL
by: Guillermo Ureña-Bailén, et al.
Published: (2022-10-01)

NKG2A gene variant predicts outcome of immunotherapy in AML and modulates the repertoire and function of NK cells
by: Brwa Ali Hussein, et al.
Published: (2023-08-01)

Expansion, persistence, and efficacy of donor memory-like NK cells infused for posttransplant relapse
by: Chen, Jianzhu
Published: (2022)

Expansion, persistence, and efficacy of donor memory-like NK cells infused for posttransplant relapse
by: Roman M. Shapiro, et al.
Published: (2022-06-01)

MRD as Biomarker for Response to Donor Lymphocyte Infusion after Allogeneic Hematopoietic Cell Transplantation in Patients with AML
by: Katrin Teich, et al.
Published: (2023-08-01)